Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK)
Historical Holders from Q3 2024 to Q3 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Symbol
-
VTAK on NYSE
-
Shares outstanding
-
22,457,615
-
Price per share
-
$0.15
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
0
-
Total reported value
-
$0
-
Share change
-
-496,945
-
Value change
-
-$120,200
-
Number of holders
-
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
ARMISTICE CAPITAL, LLC
|
5%
|
-50%
|
$257,746
|
+$27,551
|
1,120,635
|
+12%
|
Armistice Capital, LLC
|
30 Jun 2025
|
|
Jenkins Casey A.
|
9.9%
|
|
$233,028
|
|
832,243
|
|
Jenkins Casey A.
|
31 Dec 2024
|
|
JENKINS DAVID A
|
2.1%
|
|
$54,371
|
|
194,182
|
|
JENKINS DAVID A
|
29 Jan 2025
|
As of 30 Sep 2025,
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has
0
institutional shareholders
filing 13F forms.
They reported no common stock holdings, but disclosed options positions.
Institutional Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
0
|
$0
|
-$120,200
|
|
|
$0.15
|
0
|
|
2025 Q2
|
496,945
|
$120,200
|
-$72,444
|
|
|
$0.24
|
12
|
|
2025 Q1
|
588,048
|
$202,288
|
+$35,854
|
|
|
$0.34
|
10
|
|
2024 Q4
|
480,473
|
$216,693
|
+$147,700
|
|
|
$0.45
|
8
|
|
2024 Q3
|
161,107
|
$62,807
|
+$62,807
|
|
|
$0.40
|
10
|